PepGen is a company based in Boston, Massachusetts that is focused on transforming the treatment of neuromuscular diseases. They are driven by their proprietary Enhanced Delivery Oligonucleotide (EDO) platform and are creating a pipeline of innovative therapies. With a team of experts and collaborations with institutions like Boston Children's Hospital, PepGen is dedicated to making a difference in the field of healthcare.

PepGen, profile picture · PepGen. RA II. 2022 - Present. Boston, Massachusetts. Boston Children's Hospital, profile picture · Boston Children's Hospital. 2021 - ...

NEWS RELEASES | PepGen. The Investor Relations website contains information about PepGen's business for stockholders, potential investors, and financial ...

PepGen | 5910 followers on LinkedIn. Transforming the Treatment of Neuromuscular Diseases | Driven by our proprietary Enhanced Delivery Oligonucleotide ...

PepGen

Find contacts at this company